US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist

5.210
-0.560-9.71%

Close Aug 16 16:00 ET

5.210
0.0000.00%

Post 20:01 ET

286.68MMarket Cap-2943P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prelude Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Prelude Therapeutics Earnings Reports

Prelude Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:26 ET

Prelude Therapeutics | 10-Q: Q1 2024 Earnings Report

May 7 07:24 ET

Prelude Therapeutics | 10-K: FY2023 Annual Report

Feb 15 17:28 ET

Prelude Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 1, 2023 16:37 ET

Analyst Rating

Updated: Aug 18, 2024

Underper form

Buy
33.33%
Hold
0.00%
Sell
66.67%

Price Target

No Data

Heat List

Overall